Navigation Links
Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database

usefulness of the ProChart data to help them define the WWOX pathway and its role in tumor suppression.

While Cytogen's internal research and development initiatives focus on clinical-stage opportunities, the Company complements its internal programs with an active business development strategy, which includes capitalizing on the promising proprietary technology platforms, such as ProChart, previously developed through its AxCell BioSciences research-stage subsidiary.

In view of recent biological validation, as well as the progress of internal data mining efforts and external research collaborations, Cytogen is exploring strategic transactions for AxCell BioSciences and will be presenting today at the 9th Annual C21 BioVentures Conference (C21) taking place in Monterey, California.

About ProChart(TM)

ProChart is a proprietary, comprehensive, experimentally validated database of protein-protein signaling interactions mediated by WW, SH3, PDZ, and other modular domain families. Cytogen believes the application of ProChart may accelerate research and drug development by: (i) discovering novel signal transduction pathways and their relevant protein-protein interactions; (ii) rapidly identifying qualified drug targets; (iii) identifying potential unwanted side effects; (iv) identifying structure and activity relationship (SAR) information regarding domain and ligand interactions that can facilitate small molecule drug design; and (v) providing high throughput screening reagents (eg, cloned domains and ligands).

About Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets three therapeutic products and one diagnostic product to the U.S. oncology market. CAPHOSOL(R) is an advanced electrolyte solution for the treatment of oral mucositis and d
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
2. Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting
3. New Data for Cytogens QUADRAMET Reported at Annual ASCO Meeting
4. Preclinical Data on Cytogens Technology to be Reported at the AACR Annual Meeting
5. New Clinical Data for Cytogens Quadramet and Prostacint to be Reported at Upcoming Major Medical Meetings
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece

Post Your Comments:
(Date:11/30/2009)..., KING OF PRUSSIA, Pa., Nov. 30 C...ompletion of a Phase I study of CPSI-2364, its ora...tion of TNF-alpha and other pro-inflammatory cytok... escalation study in healthy volunteers confirm th...ing. ,, All 30 enrolled subjects completed th...
(Date:11/30/2009)... , WALTHAM, Mass., Nov. 30 Ac...obal authority on medical technology market intell...ctable market declined by almost 5% over 2008 as p...sult of the economic crisis. The market will, howe...urn to the strong pre-recession growth rates of ov...
(Date:11/30/2009)..., ATLANTA, Nov. 30 Amoena USA C...reast care products, is sponsoring the 4th Annual ...irst time, Amoena will honor survivors and the peo...ding a cabin for the one with the most inspiration...oena wants to hear about young mothers who bravely...
Breaking Medicine Technology:Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results 12467 1Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results 12467 2Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results 12467 3Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 1Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 2Recovery Audit Contractor Connolly Healthcare Licenses Milliman Care Guidelines 28R 29 47886 3Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control 28APIC 29 Annual Conference 47882 1Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control 28APIC 29 Annual Conference 47882 2Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control 28APIC 29 Annual Conference 47882 3
(Date:11/30/2009)...unique online and mobile tool empowers patients to...isions ,, ARLINGTON, Va., Nov. 30 /PRNewswir...#1 HIV/AIDS resource online, today launched My Hea...V/AIDS-infected patients the ability to save, trac...d with sponsorship from Merck, is available at ww...
(Date:11/30/2009)... Nov. 30 A new poll released t...Foundation Center for Health Policy at the Univers...a, shows a widespread consensus among the Latino/H...are reform and indicates significant support for e...are tops the list of national issues identified by...
(Date:11/30/2009)...Newswire/ -- Harrington Physician Services (HPS) i...ice physicians Martin Devine, Leah Doret, Elizabet...e. ,, These four esteemed and popular Charlto... will soon join the Harrington family in the new H...ilding under construction at 10 North Main Street,...
(Date:11/30/2009)...RNewswire/ -- Of the more than one million people ... nearly half are African American. Moreover, the H...urpassed the threshold for a severe epidemic three...90 percent of all women infected with the virus in...:00 p.m.*, World AIDS Day, BET shines a light on t...
(Date:11/30/2009)...PRNewswire/ -- The launch of Invivo Corporation,s ...rst FDA-cleared, fully-automated morphological sys...t of suspicious breast lesions. The ONCAD system w...iety of North America 2009 Annual Meeting in Chica...perts in breast MRI, ONCAD for DynaCAD uses a pate...
Breaking Medicine News(10 mins):Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3
...esteem and health of people, according to Penn Sta...vels of psychological distress when compared to th...ears, as many as 1,150 people in unhappy // marri...py marriage would lead to a greater improvement of...
...search which said that fish was capable of scaling...which are present in fish do not serve to reduce c...r incidence of cancer has however been // witnesse...y acids on cancer treatment by adding it to the di...
...oposed the administration of flu vaccine to all ch...to prevent the incidence of seasonal flu. The drea...he population during winter, had claimed the valua...rovides related advice to the Government has taken...
...rt “Hope Lodges” near major cancer hospitals to pr...hey are getting treatment in these major cancer ho...e accommodation to these patients who are coming f...void unnecessary travel from the patients home tow...
...sociation has launched a hospital information webs...ity of treatment// offered by the hospital which w... hospital for their treatment. There are 35 St...umber of different procedures done in each special...
...hengcheng Zhang from Whitehead Institute for Biome...on of growth factors// which enriches and increase...e it could be injected into the recipient. St...m cells for therapeutic treatment are isolated fro...
Other Medicine News:
...ainless steel, detachable disposable concentric ne...nd a 2-mm (.08-in) brass plug connector. Needles s... cable with 5-pin DIN connector is sold separately... be autoclaved or disinfected (page 34). A starter...
...features a dual-detection technology to provide ad...children under age 5 with a simple, easy-to-use pr...nutes. This combination of performance, and ease-o...ssary ancillary testing, improve appropriate treat...
ImmunoCard STAT! Rotavirus
... A Strep test delivers excellent sensitivity and s... a simple, easy-to-use test that provides an answe...d services enable you to provide improved patient ...ts of waived laboratories. Find out what value we ...
Medicine Products: